Testing effectiveness (Phase 2)Not Yet RecruitingNCT07209163
What this trial is testing
Combination Therapy With Tazemetostat in Relapsed and Refractory Peripheral T-cell Lymphoma
Who this might be right for
Peripheral T Cell Lymphoma
Ruijin Hospital 48